James M S Wason (J M S Wason, James Ms Wason, James Wason)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 41

Top Venues

BMJ open

Statistics in medicine

Biometrics

Pharmaceutical statistics

Newcastle University

University of Cambridge (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Newcastle University Jul 1o 2017

United Kingdom

Professor of Biostatistics :: Institute of Health and Society

Education History

University of Cambridge Oct 1o 2006 - Oct 17o 2009

United Kingdom

PHD :: MRC Biostatistics Unit

Publications

Toshiaki A Furawaka, Aran Tajika, Masatsugu Sakata, Yan Luo, Rie Toyomoto, Masaru Horikoshi, Tatsuo Akechi, Norito Kawakami, Takeo Nakayama, Naoki Kondo, Shingo Fukuma, Hisashi Noma, Helen Christensen, Ronald C Kessler, Pim Cuijpers, James M S Wason
Four 2×2 factorial trials of smartphone CBT to reduce subthreshold depression and to prevent new depressive episodes among adults in the community-RESiLIENT trial (Resilience Enhancement with Smartphone in LIving ENvironmenTs): a master protocol. BMJ open 13 (2) (2023)
Theophile Bigirumurame, Shaun Kuan Wei Hiu, Marion Dawn Teare, James M S Wason, Andrew Bryant, Matthew Breckons
Current practices in studies applying the target trial emulation framework: a protocol for a systematic review. BMJ open 13 (6) (2023)
Miranda Morton, Nina Wilson, Tara Marie Homer, Laura Simms, Alison Steel, Rebecca Maier, James M S Wason, Laura Ternent, Alaa Abouhajar, Maria Allen, Richard Joyce, Victoria Hildreth, Rachel Lakey, Svetlana Cherlin, Adam Walker, Graham Devereux, James D Chalmers, Adam T Hill, Charles Haworth, John R Hurst, Anthony De Soyza
Dual bronchodilators in Bronchiectasis study (DIBS): protocol for a pragmatic, multicentre, placebo-controlled, three-arm, double-blinded, randomised controlled trial studying bronchodilators in preventing exacerbations of bronchiectasis. BMJ open 13 (8) (2023)
Toshiaki A Furawaka, Aran Tajika, Masatsugu Sakata, Yan Luo, Rie Toyomoto, Masaru Horikoshi, Tatsuo Akechi, Norito Kawakami, Takeo Nakayama, Naoki Kondo, Shingo Fukuma, Hisashi Noma, Helen Christensen, Ronald C Kessler, Pim Cuijpers, James M S Wason
Four 2×2 factorial trials of smartphone CBT to reduce subthreshold depression and to prevent new depressive episodes among adults in the community-RESiLIENT trial (Resilience Enhancement with Smartphone in LIving ENvironmenTs): a master protocol. BMJ open 13 (2) (2023)
David S Robertson, James M S Wason, Franz Koenig, Martin Posch, Thomas F Jaki
Online error rate control for platform trials. Statistics in medicine (2023)
Toshiaki A Furawaka, Aran Tajika, Masatsugu Sakata, Yan Luo, Rie Toyomoto, Masaru Horikoshi, Tatsuo Akechi, Norito Kawakami, Takeo Nakayama, Naoki Kondo, Shingo Fukuma, Hisashi Noma, Helen Christensen, Ronald C Kessler, Pim Cuijpers, James M S Wason
Four 2×2 factorial trials of smartphone CBT to reduce subthreshold depression and to prevent new depressive episodes among adults in the community-RESiLIENT trial (Resilience Enhancement with Smartphone in LIving ENvironmenTs): a master protocol. BMJ open 13 (2) (2023)
Theophile Bigirumurame, Shaun Kuan Wei Hiu, Marion Dawn Teare, James M S Wason, Andrew Bryant, Matthew Breckons
Current practices in studies applying the target trial emulation framework: a protocol for a systematic review. BMJ open 13 (6) (2023)
Lou E Whitehead, Oliver Sailer, Miles D Witham, James M S Wason
Bayesian borrowing for basket trials with longitudinal outcomes. Statistics in medicine (2023)
Theophile Bigirumurame, Shaun Kuan Wei Hiu, Marion Dawn Teare, James M S Wason, Andrew Bryant, Matthew Breckons
Current practices in studies applying the target trial emulation framework: a protocol for a systematic review. BMJ open 13 (6) (2023)
Lou E Whitehead, Oliver Sailer, Miles D Witham, James M S Wason
Bayesian borrowing for basket trials with longitudinal outcomes. Statistics in medicine (2023)
Toshiaki A Furawaka, Aran Tajika, Masatsugu Sakata, Yan Luo, Rie Toyomoto, Masaru Horikoshi, Tatsuo Akechi, Norito Kawakami, Takeo Nakayama, Naoki Kondo, Shingo Fukuma, Hisashi Noma, Helen Christensen, Ronald C Kessler, Pim Cuijpers, James M S Wason
Four 2×2 factorial trials of smartphone CBT to reduce subthreshold depression and to prevent new depressive episodes among adults in the community-RESiLIENT trial (Resilience Enhancement with Smartphone in LIving ENvironmenTs): a master protocol. BMJ open 13 (2) (2023)
Toshiaki A Furawaka, Aran Tajika, Masatsugu Sakata, Yan Luo, Rie Toyomoto, Masaru Horikoshi, Tatsuo Akechi, Norito Kawakami, Takeo Nakayama, Naoki Kondo, Shingo Fukuma, Hisashi Noma, Helen Christensen, Ronald C Kessler, Pim Cuijpers, James M S Wason
Four 2×2 factorial trials of smartphone CBT to reduce subthreshold depression and to prevent new depressive episodes among adults in the community-RESiLIENT trial (Resilience Enhancement with Smartphone in LIving ENvironmenTs): a master protocol. BMJ open 13 (2) (2023)
Luke Ondijo Ouma, Michael John Grayling, James M S Wason, Haiyan Zheng
Bayesian modelling strategies for borrowing of information in randomised basket trials. Journal of the Royal Statistical Society. Series C, Applied statistics 71 (5) (2022)
Katherine J Rennie, Miles D Witham, Penny Bradley, Andrew Clegg, Stephen Connolly, Helen C Hancock, Shaun Hiu, Leanne Marsay, Claire McDonald, Laura Robertson, Laura Simms, Alison J Steel, Claire J Steves, Bryony Storey, James M S Wason, Nina Wilson, Thomas von Zglinicki, Avan A P Sayer
MET-PREVENT: metformin to improve physical performance in older people with sarcopenia and physical prefrailty/frailty - protocol for a double-blind, randomised controlled proof-of-concept trial. BMJ open 12 (7) (2022)
James M S Wason, Munyaradzi Dimairo, Katie Biggs, Sarah Bowden, Julia M Brown, Laura Flight, Jamie Hall, Thomas F Jaki, Rachel Lowe, Philip Pallmann, Mark A Pilling, Claire Snowdon, Matthew R Sydes, Sofía S Villar, Christopher J Weir, Nina Wilson, Christina Yap, Helen C Hancock, Rebecca H Maier
Practical guidance for planning resources required to support publicly-funded adaptive clinical trials. BMC medicine 20 (1) (2022)
Vivien Li, Baptiste Leurent, Frederik Barkhof, Marie Braisher, Fay Cafferty, Olga Ciccarelli, E Ann Yeh, Emma Gray, Jennifer M Nicholas, Mahesh K B Parmar, Guy Peryer, Jenny Robertson, Nigel Stallard, James M S Wason, Jeremy Chataway
Designing Multi-arm Multistage Adaptive Trials for Neuroprotection in Progressive Multiple Sclerosis. Neurology 98 (18) (2022)
Luke Ondijo Ouma, Michael John Grayling, James M S Wason, Haiyan Zheng
Bayesian modelling strategies for borrowing of information in randomised basket trials. Journal of the Royal Statistical Society. Series C, Applied statistics 71 (5) (2022)
Luke Ondijo Ouma, Michael John Grayling, James M S Wason, Haiyan Zheng
Bayesian modelling strategies for borrowing of information in randomised basket trials. Journal of the Royal Statistical Society. Series C, Applied statistics 71 (5) (2022)
Kevin Kunzmann, Michael John Grayling, Kim May Lee, David S Robertson, Kaspar Rufibach, James M S Wason
Conditional power and friends: The why and how of (un)planned, unblinded sample size recalculations in confirmatory trials. Statistics in medicine 41 (5) (2022)
Martina E McMenamin, Jessica K Barrett, Anna Berglind, James M S Wason
Sample size estimation using a latent variable model for mixed outcome co-primary, multiple primary and composite endpoints. Statistics in medicine 41 (13) (2022)
Samuel K Sarkodie, James M S Wason, Michael John Grayling
A hybrid approach to comparing parallel-group and stepped-wedge cluster-randomized trials with a continuous primary outcome when there is uncertainty in the intra-cluster correlation. Clinical trials (London, England) (2022)
James M S Wason
Discussion on "Adaptive enrichment designs with a continuous biomarker" by Nigel Stallard. Biometrics (2022)
Michael John Grayling, James M S Wason, Sofía S Villar
Response adaptive intervention allocation in stepped-wedge cluster randomized trials. Statistics in medicine 41 (6) (2022)
Michael John Grayling, James M S Wason
Point estimation following a two-stage group sequential trial. Statistical methods in medical research (2022)
Haiyan Zheng, Thomas Jaki, James M S Wason
Bayesian sample size determination using commensurate priors to leverage preexperimental data. Biometrics (2022)
Rachid Abbas, James M S Wason, Stefan Michiels, Gwénaël Le Teuff
A two-stage drop-the-losers design for time-to-event outcome using a historical control arm. Pharmaceutical statistics (2021)
Helen Mossop, Michael John Grayling, Ferdia A Gallagher, Sarah J Welsh, Grant D Stewart, James M S Wason
Advantages of multi-arm non-randomised sequentially allocated cohort designs for Phase II oncology trials. British journal of cancer (2021)
Nina Wilson, Katie Biggs, Sarah Bowden, Julia Brown, Munyaradzi Dimairo, Laura Flight, Jamie Hall, Anna Hockaday, Thomas Jaki, Rachel Lowe, Caroline Murphy, Philip Pallmann, Mark A Pilling, Claire Snowdon, Matthew R Sydes, Sofía S Villar, Christopher J Weir, Jessica Welburn, Christina Yap, Rebecca Maier, Helen Hancock, James M S Wason
Costs and staffing resource requirements for adaptive clinical trials: quantitative and qualitative results from the Costing Adaptive Trials project. BMC medicine 19 (1) (2021)
Luke Ondijo Ouma, Michael J Grayling, Haiyan Zheng, James M S Wason
Treatment allocation strategies for umbrella trials in the presence of multiple biomarkers: A comparison of methods. Pharmaceutical statistics 20 (6) (2021)
Jixiong Wang, Ashish Patel, James M S Wason, Paul J Newcombe
Two-stage penalized regression screening to detect biomarker-treatment interactions in randomized clinical trials. Biometrics (2021)
Ramona Woitek, Mary A McLean, Stephan Ursprung, Oscar M Rueda, Raquel Manzano Garcia, Matthew J Locke, Lucian Beer, Gabrielle Baxter, Leonardo Rundo, Elena Provenzano, Joshua Kaggie, Andrew Patterson, Amy Frary, Johanna Field-Rayner, Vasiliki Papalouka, Justine Kane, Arnold J V Benjamin, Andrew B Gill, Andrew N Priest, David Y Lewis, Roslin Russell, Ashley Grimmer, Brian White, Beth Latimer-Bowman, Ilse Patterson, Amy Schiller, Bruno Carmo, Rhys Slough, Titus Lanz, James M S Wason, Rolf F Schulte, Suet-Feung Chin, Martin J Graves, Fiona J Gilbert, Jean E Abraham, Carlos Caldas, Kevin M Brindle, Evis Sala, Ferdia A Gallagher
Hyperpolarized Carbon-13 MRI for Early Response Assessment of Neoadjuvant Chemotherapy in Breast Cancer Patients. Cancer research 81 (23) (2021)
Alexis Collins, Dennis William Lendrem, James M S Wason, Jessica R Tarn, Nadia Howard-Tripp, Iris L A Bodewes, Marjan A Versnel, Jacques-Eric Gottenberg, Raphaèle Seror, Xavier Mariette, Wan-Fai Ng
Revisiting the JOQUER trial: stratification of primary Sjögren's syndrome and the clinical and interferon response to hydroxychloroquine. Rheumatology international 41 (9) (2021)
Michael J Grayling, Theophile Bigirumurame, Svetlana Cherlin, Luke Ouma, Haiyan Zheng, James M S Wason
Innovative trial approaches in immune-mediated inflammatory diseases: current use and future potential. BMC rheumatology 5 (1) (2021)
James M S Wason, David S Robertson
Controlling type I error rates in multi-arm clinical trials: A case for the false discovery rate. Pharmaceutical statistics 20 (1) (2020)
James M S Wason, Martina McMenamin, Susanna Dodd
Analysis of responder-based endpoints: improving power through utilising continuous components. Trials 21 (1) (2020)
Martina E McMenamin, Jessica K Barrett, Anna Berglind, James M S Wason
Employing a latent variable framework to improve efficiency in composite endpoint analysis. Statistical methods in medical research 30 (3) (2020)
Nigel Stallard, Lisa Hampson, Norbert Benda, Werner Brannath, Thomas Burnett, Tim Friede, Peter K Kimani, Franz Koenig, Johannes Krisam, Pavel Mozgunov, Martin Posch, James M S Wason, Gernot Wassmer, John Whitehead, S Faye Williamson, Sarah Zohar, Thomas F Jaki
Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19. Statistics in biopharmaceutical research 12 (4) (2020)
James M S Wason, Shaun R Seaman
A latent variable model for improving inference in trials assessing the effect of dose on toxicity and composite efficacy endpoints. Statistical methods in medical research 29 (1) (2019)
James M S Wason, Peter Brocklehurst, Christina Yap
When to keep it simple - adaptive designs are not always useful. BMC medicine 17 (1) (2019)
David S Robertson, James M S Wason
Familywise error control in multi-armed response-adaptive trials. Biometrics 75 (3) (2019)
Thomas Jaki, James M S Wason
Multi-arm multi-stage trials can improve the efficiency of finding effective treatments for stroke: a case study. BMC cardiovascular disorders 18 (1) (2018)

James M S Wason.css-eqlu8i{font-size:small;padding-left:4px;} (J M S Wason, James Ms Wason, James Wason)

Publication Activity (10 Years)

Top Topics

Top Venues

James M S Wason (J M S Wason, James Ms Wason, James Wason)